"There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
26 Sep 2024
Historique:
received: 19 07 2024
accepted: 04 09 2024
revised: 19 07 2024
medline: 26 9 2024
pubmed: 26 9 2024
entrez: 26 9 2024
Statut: epublish

Résumé

Although the largest increase in melanoma incidence is observed for localised melanoma, little research has been done on its impact. Despite favourable prognoses and relatively short treatment trajectories, diagnosis and treatment may significantly impact life post-treatment. Therefore, the aim of this study was to gain an in-depth understanding of stage I and II melanoma survivors' experiences resuming life after treatment and their associated survivorship care (SSC) needs. A qualitative focus group study was conducted with 18 stage I or II melanoma survivors, divided over three focus groups with 6 survivors each. Transcripts were analysed through thorough thematic content analysis, using multiple phases of coding. In resuming life, survivors experienced profound initial impacts of disease and treatment, fed by a perceived lack of knowledge and underestimation of melanoma. They faced unexpected physical and emotional effects post-surgery, experiencing mixed feelings from relief to fear and uncertainty. Survivors felt misunderstood, had to adjust their lives, and managed personal and external expectations while experiencing a positive shift in life perspective, leading to a notable difference in life before and after cancer. In terms of SSC needs, survivors stressed the need for tailored information, accessible resources, patient-centered follow-up, and supportive care addressing the total impact of disease and treatment. These findings highlight the importance of improving melanoma awareness and providing holistic SSC not only to advanced, but also to localised melanoma survivors. A tailored survivorship care plan could facilitate access to information and supportive care, helping patients resume their lives.

Identifiants

pubmed: 39325191
doi: 10.1007/s00403-024-03376-4
pii: 10.1007/s00403-024-03376-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

645

Informations de copyright

© 2024. The Author(s).

Références

Cancer TODAY | IARC - https://gco.iarc.who.int. Data version: Globocan 2022 (version 1.1) – 08.02.2024: International Agency for Research on Cancer. World Health Organization.; [ https://gco.iarc.fr/today/en/dataviz/pie?mode=population&group_populations=0&cancers=16
Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen J, Wakkee M et al (2021) Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): a nationwide population-based study. Eur J Cancer 154:111–119
doi: 10.1016/j.ejca.2021.06.007 pubmed: 34256280
Keung EZ, Gershenwald JE (2018) The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther 18(8):775–784
doi: 10.1080/14737140.2018.1489246 pubmed: 29923435 pmcid: 7652033
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer 170:236–255
doi: 10.1016/j.ejca.2022.03.008 pubmed: 35570085
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022. Eur J Cancer 170:256–284
doi: 10.1016/j.ejca.2022.04.018 pubmed: 35623961
Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472–492
doi: 10.3322/caac.21409 pubmed: 29028110 pmcid: 5978683
van der Kamminga NCW, Joosen MCW, de Joode K, Joosse A, Grunhagen DJ et al (2022) Experiences of resuling life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma. Br J Dermatol
Dunn J, Watson M, Aitken JF, Hyde MK (2017) Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology 26(11):1722–1731
doi: 10.1002/pon.4290 pubmed: 27696578
Buiting HM, van Ark MAC, Dethmers O, Maats EPE, Stoker JA, Sonke GS (2019) Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands. BMJ Open 9(3):e024450
doi: 10.1136/bmjopen-2018-024450 pubmed: 30928932 pmcid: 6475444
van der Zwanenburg LC, Koldenhof JJ, Suijkerbuijk KPM, Schellekens MPJ (2024) What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study. Support Care Cancer 32(4):222
doi: 10.1007/s00520-024-08398-2 pubmed: 38470541 pmcid: 10933145
Raducu L, Avino A, Purnichescu Purtan R, Balcangiu-Stroescu AE, Balan DG, Timofte D et al (2020) Quality of life in patients with surgically removed skin tumors. Med (Kaunas). ;56(2)
Mahama AN, Haller CN, Labrada J, Idiong CI, Haynes AB, Jacobs EA et al (2024) Lived experiences and fear of Cancer Recurrence among survivors of localized cutaneous melanoma. JAMA Dermatol
van de Holterhues C, de Vries E, Neumann HA, Nijsten TE (2012) Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population. J Eur Acad Dermatol Venereol 26(11):1389–1395
doi: 10.1111/j.1468-3083.2011.04297.x pubmed: 22035105
Hewitt M, Greenfield S, Stovall E (2005) Lost in transition. From cancer patient to cancer survivor. :1–506
Wolner ZJ, Flowers NI, Yushak ML, Chen SC, Yeung H (2021) Exploring the melanoma survivorship experience: a qualitative study. Br J Dermatol 185(1):221–223
doi: 10.1111/bjd.19868 pubmed: 33544884 pmcid: 8254737
Kamminga NCW, Wakkee M, De Bruin RJ, Joosse A, Reeder SWI et al (2023) Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study. BMC Cancer 23(1):278
doi: 10.1186/s12885-023-10759-9 pubmed: 36973713 pmcid: 10042579
Husson O, Holterhues C, Mols F, van de Nijsten T (2010) Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol 163(4):879–881
doi: 10.1111/j.1365-2133.2010.09895.x pubmed: 20854404
Green J, Thorogood N (2018) Qualitative methodology in health research. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd
Bazen A, Barg FK, Takeshita J (2021) Research Techniques made simple: an introduction to qualitative research. J Invest Dermatol 141(2):241–7e1
doi: 10.1016/j.jid.2020.11.029 pubmed: 33504436
Green J, Thorogood N (2018) Group interviews and discussions. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd
O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA (2014) Standards for reporting qualitative research: a synthesis of recommendations. Acad Med 89(9):1245–1251
doi: 10.1097/ACM.0000000000000388 pubmed: 24979285
Bloor M, Wood F (2016) Keywords in qualitative methods: purposive sampling. Qualitative evaluation and research methods, 2nd edn. SAGE, Newbury Park, CA
Hennink MM, Kaiser BN, Marconi VC (2017) Code saturation versus meaning saturation: how many interviews are Enough? Qual Health Res 27(4):591–608
doi: 10.1177/1049732316665344 pubmed: 27670770
de Rooij BH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen R et al (2019) Patients’ information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: new insights for tailored delivery. Cancer 125(5):788–797
doi: 10.1002/cncr.31844 pubmed: 30500067
Green J, Thorogood N (2018) Developing qualitative analysis. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd
Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago
Constant Comparison. In (2008) In: Given LM (ed) The SAGE encyclopedia of qualitative research methods. 2. Los Angeles. SAGE, Calif, pp 114–115
Kelati A, Baybay H, Atassi M, Elfakir S, Gallouj S, Meziane M et al (2017) Skin cancer knowledge and attitudes in the region of Fez, Morocco: a cross-sectional study. BMC Dermatol 17(1):2
doi: 10.1186/s12895-017-0055-8 pubmed: 28212650 pmcid: 5316218
Rocholl M, Ludewig M, John SM, Bitzer EM, Wilke A (2020) Outdoor workers’ perceptions of skin cancer risk and attitudes to sun-protective measures: a qualitative study. J Occup Health 62(1):e12083
doi: 10.1002/1348-9585.12083 pubmed: 31478315
Korta DZ, Saggar V, Wu TP, Sanchez M (2014) Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic. J Am Acad Dermatol 70(2):312–317
doi: 10.1016/j.jaad.2013.10.030 pubmed: 24332312
Verkissen MN, Ezendam NP, Fransen MP, Essink-Bot ML, Aarts MJ, Nicolaije KA et al (2014) The role of health literacy in perceived information provision and satisfaction among women with ovarian tumors: a study from the population-based PROFILES registry. Patient Educ Couns 95(3):421–428
doi: 10.1016/j.pec.2014.03.008 pubmed: 24698535
Gabrijel S, Grize L, Helfenstein E, Brutsche M, Grossman P, Tamm M et al (2008) Receiving the diagnosis of lung cancer: patient recall of information and satisfaction with physician communication. J Clin Oncol 26(2):297–302
doi: 10.1200/JCO.2007.13.0609 pubmed: 18182671
Nguyen MH, Smets EMA, Bol N, Bronner MB, Tytgat K, Loos EF et al (2019) Fear and forget: how anxiety impacts information recall in newly diagnosed cancer patients visiting a fast-track clinic. Acta Oncol 58(2):182–188
doi: 10.1080/0284186X.2018.1512156 pubmed: 30264632
Bakker MM, Luttikhuis T, Putrik P, Jansen I, Rademakers J, de Wit M et al (2022) Consideration of health literacy in patient information: a mixed-methods study of COVID-19 crisis communication in Dutch rheumatology. BMC Rheumatol 6(1):52
doi: 10.1186/s41927-022-00283-x pubmed: 36068591 pmcid: 9449268
Rodriguez-Gonzalez A, Carmona-Bayonas A, Hernandez San Gil R, Cruz-Castellanos P, Antonanzas-Basa M, Lorente-Estelles D et al (2023) Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer. Clin Transl Oncol 25(12):3492–3500
doi: 10.1007/s12094-023-03214-5 pubmed: 37247131
Lardas M, van den Liew M, De Santis M, Van den Bellmunt J et al (2017) Quality of life outcomes after primary treatment for clinically localised prostate Cancer: a systematic review. Eur Urol 72(6):869–885
doi: 10.1016/j.eururo.2017.06.035 pubmed: 28757301
Fraterman I, Glaser SLC, Wilgenhof S, Medlock SK, Mallo HA, Cornet R et al (2022) Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study. Support Care Cancer 30(9):7249–7260
doi: 10.1007/s00520-022-07133-z pubmed: 35589878 pmcid: 9119379
Dieng M, Smit AK, Hersch J, Morton RL, Cust AE, Irwig L et al (2019) Patients’ views about skin self-examination after treatment for localized Melanoma. JAMA Dermatol 155(8):914–921
doi: 10.1001/jamadermatol.2019.0434 pubmed: 31090868 pmcid: 6537768
Ackermann DM, Dieng M, Medcalf E, Jenkins MC, van Kemenade CH, Janda M et al (2022) Assessing the potential for patient-led Surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial. JAMA Dermatol 158(1):33–42
doi: 10.1001/jamadermatol.2021.4704 pubmed: 34817543
Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L et al (2022) Prognosis of patients with primary Melanoma Stage I and II according to American Joint Committee on Cancer Version 8 validated in two independent cohorts: implications for adjuvant treatment. J Clin Oncol 40(32):3741–3749
doi: 10.1200/JCO.22.00202 pubmed: 35709414 pmcid: 9649277

Auteurs

N C W Kamminga (NCW)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

J E C Kievits (JEC)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Surgical Oncology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

M Wakkee (M)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

S G W van Loon (SGWV)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

M C W Joosen (MCW)

Department Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.

D Verver (D)

Department of Surgery, Franciscus Gasthuis, Rotterdam, The Netherlands.

K Munte (K)

Department of Dermatology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.

P W P Plaisier (PWP)

Department of Surgical Oncology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

J A C Rietjens (JAC)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Design Organisation and Strategy, Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.

T E C Nijsten (TEC)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

M Lugtenberg (M)

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. m.lugtenberg@erasmusmc.nl.
Department Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands. m.lugtenberg@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH